Insider Shareholders with Direct Ownership of Artiva Biotherapeutics, Inc. (RTVA)
This section provides a comprehensive overview of the insiders with direct ownership of Artiva Biotherapeutics, Inc. (RTVA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Artiva Biotherapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 1,936,637 | 0 | 1,936,637 | 1 |
Jul 22, 2024
Added 17.71%
|
|
|
Fred Aslan
President and CEO |
228,905 | 0 | 228,905 | 1 |
Jul 22, 2024
Added 50.0%
|
| 194,108 | 0 | 194,108 | 1 |
Jul 22, 2024
Added 20.16%
|
|
|
Jennifer Bush
COO, CLO, Secy, Compliance Off |
136,650 | 0 | 159,449 | 2 |
Feb 26, 2025
Added 35.21%
|
|
Neha Krishnamohan
Chief Financial Officer |
110,000 | 0 | 110,000 | 2 |
Feb 26, 2025
Added 35.29%
|
|
Christopher Horan
Chief Tech Operations Officer |
85,000 | 0 | 85,000 | 2 |
Feb 26, 2025
Added 41.38%
|
|
Thorsten Graef
Chief Medical Officer |
80,000 | 0 | 80,000 | 2 |
Feb 26, 2025
Added 42.86%
|
|
Heather Raymon
SVP, Research and Development |
43,350 | 0 | 43,350 | 2 |
Feb 26, 2025
Added 43.48%
|
| 2,958,063 | 0 | 0 | 1 |
N/A
|